Biopharma employees report gains in compensation and job satisfaction, as industry growth continues.
Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.
Performing degradation studies is the best strategy to evaluate toxicity risk.
New organization offers support to contract research organizations and contract manufacturing organizations in the New England area.
Trends and best practices for the use of outsourcing serivces, pricing models, contract manufacturing, facility development and location activities, and clinical trial services.
European CDMOs want into the US market, but entry options are limited.
FDA has scheduled a public meeting in early January to assess and weigh data on the first United States application for a biosimilar therapy.
The agency publishes two guidance documents on providing regulatory submissions in electronic format.
A statement from GPhA’s president expresses the organization’s support of FDA’s proposed rule to amend labeling regulations.